CAIRO – 27 April 2022: Arqaam Brokerage Company announced that the seventh investment company, the subsidiary of the Saudi Public Investment Fund (the sovereign fund) has raised its stake in the capital of Tenth of Ramadan Pharmaceutical Industries...اقرأ المزيد
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) expected its operating profits before tax, interest, depreciation and amortization to decrease by 11.7 percent, to reach about LE 255 million in 2019, compared to LE 289 million...اقرأ المزيد